For example, Aird et al. has shown that knockdown of RRM2 triggers aberrant DNA replication, activation of the DNA damage response and cellular senescence in primary cells and cancer cell lines, including melanoma and ovarian cancer [59–61]. This evidence concerns the gene RRM2 and ovarian carcinoma.